Denali Therapeutics (DNLI) Invested Capital (2022 - 2025)
Denali Therapeutics (DNLI) posted quarterly Invested Capital of $5.6 million for Q4 2025, down 39.89% year-over-year from $9.3 million in Q4 2024, and little changed quarter-over-quarter from $5.6 million in Q3 2025.
Denali Therapeutics (DNLI) Invested Capital (2022 - 2025) Analysis & Trends
Denali Therapeutics (DNLI) has reported Invested Capital for 3 consecutive years, with $5.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Invested Capital fell 39.89% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $18.2 million (down 22.59% YoY), while the FY2025 annual figure was $5.6 million, down 39.89% from the prior year.
- Invested Capital held at $5.6 million in Q4 2025 per DNLI's latest filing, from $5.6 million in the prior quarter.
- Across five years, Invested Capital topped out at $9.3 million in Q4 2024 and bottomed at $1.4 million in Q3 2022.
- Historically, Invested Capital has averaged $5.6 million across 3 years, with a median of $5.6 million in 2025.
- On a YoY basis, Invested Capital climbed as much as 0.92% in 2025 and fell as far as 39.89% in 2025.
- Denali Therapeutics' Invested Capital stood at $4.4 million in 2022, then jumped by 112.88% to $9.3 million in 2024, then plunged by 39.89% to $5.6 million in 2025.
- Business Quant data shows DNLI's Invested Capital at $5.6 million in Q4 2025, $5.6 million in Q3 2025, and $7.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Denali Therapeutics | 3.90 Bn | 3.90 Bn | 3.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.62 Mn |
| Sep 30, 2025 | 5.63 Mn |
| Jun 30, 2025 | 6.99 Mn |
| Mar 31, 2025 | 8.54 Mn |
| Dec 31, 2024 | 9.34 Mn |
| Sep 30, 2024 | 5.68 Mn |
| Dec 31, 2022 | 4.39 Mn |
| Sep 30, 2022 | 1.44 Mn |
| Mar 31, 2022 | 2.71 Mn |